Trial description:
Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study
Contact name:
Dr Ramesh Bulusu
Trial start date:
Wednesday, March 1, 2017
Trial end date:
Thursday, December 31, 2020
Trial tumour type:
Sarcoma
Show on Radiotherapy:
No
